SCHEMBL26528874

SCHEMBL26528874

Cc1ccc(/C=C/C(=O)c2ccc(O)c(O)c2O)cc1O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 1/20 0.78
MAPT P10636 3/20 0.56
KDM4E B2RXH2 2/20 0.56
ALDH1A1 P00352 1/20 0.56
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
HSP90AA1 P07900 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
KMT2A Q03164 2/20 0.55
MEN1 O00255 1/20 0.55
EGFR P00533 1/20 0.55
SRC P12931 1/20 0.55
AKR1B1 P15121 1/20 0.55
NFKB1 P19838 1/20 0.55
CDK2 P24941 1/20 0.55
HSD17B2 P37059 1/20 0.55
PIK3CA P42336 1/20 0.55
NFKB2 Q00653 1/20 0.55
RELA Q04206 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34959 0.88 TERT (1.00) TERTMAPTKDM4EKMT2AMEN1
SCHEMBL34958 0.88 TERT (1.00) TERTMAPTKDM4EKMT2AMEN1
SCHEMBL29379310 0.88 TERT (1.00) TERTMAPTKDM4EKMT2AMEN1
SCHEMBL31682981 0.88 TERT (1.00) TERTMAPTKDM4EKMT2AMEN1
SCHEMBL30383541 0.82 MEN1 (0.76) MAPTKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL17356221 0.82 MEN1 (0.76) MAPTKDM4EALDH1A1LMNASMN1; SMN2
SCHEMBL30736468 0.81 TERT (0.67) TERTMAPTKDM4EALDH1A1LMNA
SCHEMBL28488132 0.81 TERT (0.67) TERTMAPTKDM4EALDH1A1LMNA
SCHEMBL31436362 0.81 TERT (0.67) TERTMAPTKDM4EALDH1A1LMNA
SCHEMBL28273153 0.81 TERT (0.67) TERTMAPTKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230321003-A1 COMPOSITION FOR ANTI-AGING OR SKIN REGENERATION COMPRISING OKANIN POSCO CO., LTD (KR) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230321003-A1 COMPOSITION FOR ANTI-AGING OR SKIN REGENERATION COMPRISING OKANIN GLA, KRT18, LIMS1 TERT 392/4885MAPT 3538/4885KDM4E 2695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.